Search
for
Sort by
Research 631–660 of 771
- A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib
- An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
- Emerging role of baricitinib in dermatology practice: All we need to know!
- Successful hair regrowth in a Korean patient with alopecia universalis following tofacitinib treatment
- Genes and Immune Response in Alopecia Areata: Review of the Alopecia Areata Research Summit First Day Proceedings
- Refractory alopecia in lupus treated with tofacitinib — a case-based review
- Alopecia areata treatment with baricitinib: different relapse phenotypes
- Alopecia Areata of the Nails: Diagnosis and Management
- A Bibliometric Analysis of Alopecia Areata Literature over the Past 50 Years.
- Personalized Medicine in the Field of Inflammatory Skin Disorders
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- Treatment of Lichen Planopilaris With Abrocitinib
- A Case of Tofacitinib for the Treatment of Resistant Vitiligo and Sustained Repigmentation After Discontinuation
- Alopecia Areata
- Treatment of concomitant alopecia areata and systemic lupus erythematosus with ivarmacitinib: a case report and literature review
- Ruxolitinib: A novel molecule in the management of dermatological disorders
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course
- Upadacitinib for Alopecia: Current Evidence and Clinical Insights
- Continued treatment with baricitinib results in meaningful scalp responses among scalp non‐responder patients with eyebrow/eyelash regrowth in the first year
- Modern dermatology brings treatment even for alopecia areata
- Treatment of Steroid-Resistant Beard-Restricted Alopecia Areata with Baricitinib
- Alopecia Areata: Current Review
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Switching between tofacitinib and baricitinib in alopecia areata: A review of clinical response
- A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo
- Oclacitinib Treatment and Surgical Management in a Case of Periocular Eosinophilic Furunculosis and Vasculitis with Secondary Eyelid Fusion in a Diabetic Cat
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- Case Series: Gene Expression Analysis in Canine Vogt-Koyanagi-Harada/Uveodermatologic Syndrome and Vitiligo Reveals Conserved Immunopathogenesis Pathways Between Dog and Human Autoimmune Pigmentary Disorders
- P718 Observational real-world evidence on the efficacy and safety of Janus Kinase inhibitors (JAKi) in the treatment of moderate to severe Active Ulcerative Colitis (UC)
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study